Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Stitzel

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Transplantation|February 1, 1972
Inhibition of C3 conversion after allotransplantationR E Spitzer, A E Stitzel
Clinical Immunology and Immunopathology|August 1, 1996
Loss of autoantibody activity by alteration in autoantigenR E Spitzer, A E Stitzel
Lancet (London, England)|August 23, 1975
Letter: C3 standardsA E Stitzel, R E Spitzer
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1974
The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertaseA E Stitzel, R E Spitzer
In Vivo (Athens, Greece)|January 1, 1988
On the origin and control of C3NeFR E Spitzer, A E Stitzel
Transplantation|February 1, 1972
Immunochemical measurement of the inhibition of C3 conversion after allotransplantationR E Spitzer, A E Stitzel
Immunochemistry|January 1, 1976
Interaction of properdin convertase and properdin in the alternative pathway of complement activationR E Spitzer, A E Stitzel, J Urmson
Clinical Immunology and Immunopathology|September 1, 1992
On the origin of C3 nephritic factor (antibody to the alternative pathway C3 convertase): evidence for the Adam and Eve concept of autoantibody productionR E Spitzer, A E Stitzel, G Tsokos
Clinical Immunology and Immunopathology|March 1, 1992
Study of the idiotypic response to autoantibody to the alternative pathway C3/C5 convertase in normal individuals, patients with membranoproliferative glomerulonephritis, and experimental animalsR E Spitzer, A E Stitzel, G C Tsokos
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1992
Autoantibody to the alternative pathway C3/C5 convertase and its anti-idiotypic response. A study in affinityR E Spitzer, A E Stitzel, G C Tsokos
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Transplantation|February 1, 1972
Inhibition of C3 conversion after allotransplantationR E Spitzer, A E Stitzel
Clinical Immunology and Immunopathology|August 1, 1996
Loss of autoantibody activity by alteration in autoantigenR E Spitzer, A E Stitzel
Lancet (London, England)|August 23, 1975
Letter: C3 standardsA E Stitzel, R E Spitzer
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1974
The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertaseA E Stitzel, R E Spitzer
In Vivo (Athens, Greece)|January 1, 1988
On the origin and control of C3NeFR E Spitzer, A E Stitzel
Transplantation|February 1, 1972
Immunochemical measurement of the inhibition of C3 conversion after allotransplantationR E Spitzer, A E Stitzel
Immunochemistry|January 1, 1976
Interaction of properdin convertase and properdin in the alternative pathway of complement activationR E Spitzer, A E Stitzel, J Urmson
Clinical Immunology and Immunopathology|September 1, 1992
On the origin of C3 nephritic factor (antibody to the alternative pathway C3 convertase): evidence for the Adam and Eve concept of autoantibody productionR E Spitzer, A E Stitzel, G Tsokos
Clinical Immunology and Immunopathology|March 1, 1992
Study of the idiotypic response to autoantibody to the alternative pathway C3/C5 convertase in normal individuals, patients with membranoproliferative glomerulonephritis, and experimental animalsR E Spitzer, A E Stitzel, G C Tsokos
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1992
Autoantibody to the alternative pathway C3/C5 convertase and its anti-idiotypic response. A study in affinityR E Spitzer, A E Stitzel, G C Tsokos
Pageof 4